Pesquisar
Hologic Inc
HOLXAdicionar à lista de desejos
76.010USD
0.0000.00%
Horário de mercado （ET）Cotações atrasadas em 15 min
16.97BValor de mercado
31.32P/L TTM
Mais detalhes de Hologic Inc Empresa
Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.
Informações de Hologic Inc
Código da empresaHOLX
Nome da EmpresaHologic Inc
Data de listagemMar 01, 1990
CEOMacmillan (Stephen P)
Número de funcionários7070
Tipo de títulosOrdinary Share
Fim do ano fiscalMar 01
Endereço250 Campus Drive
CidadeMARLBOROUGH
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal01752
Telefone15082632900
Sitehttps://www.hologic.com/
Código da empresaHOLX
Data de listagemMar 01, 1990
CEOMacmillan (Stephen P)
Executivos da empresa Hologic Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Christiana Stamoulis
Ms. Christiana Stamoulis
Independent Director
Independent Director
48.66K
+6.56%
Mr. Mark Horvath
Mr. Mark Horvath
Division President, Breast and Skeletal Health Solutions
Division President, Breast and Skeletal Health Solutions
22.68K
-0.50%
Mr. Essex D. Mitchell
Mr. Essex D. Mitchell
Chief Operating Officer
Chief Operating Officer
20.34K
+0.41%
Mr. Brandon Schnittker
Mr. Brandon Schnittker
Division President, GYN Surgical Solutions
Division President, GYN Surgical Solutions
17.51K
-0.51%
Mr. Charles J. Dockendorff, CPA
Mr. Charles J. Dockendorff, CPA
Independent Director
Independent Director
13.51K
-49.06%
Dr. Ludwig N. Hantson, Ph.D.
Dr. Ludwig N. Hantson, Ph.D.
Independent Director
Independent Director
10.59K
+30.13%
Ms. Nanaz Mohtashami
Ms. Nanaz Mohtashami
Independent Director
Independent Director
5.51K
+57.93%
Ms. Stacey D. Stewart
Ms. Stacey D. Stewart
Independent Director
Independent Director
4.92K
+64.81%
Dr. Jennifer Schneiders, Ph.D.
Dr. Jennifer Schneiders, Ph.D.
President - Diagnostic Solutions
President - Diagnostic Solutions
--
--
Mr. Martin Madaus
Mr. Martin Madaus
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Christiana Stamoulis
Ms. Christiana Stamoulis
Independent Director
Independent Director
48.66K
+6.56%
Mr. Mark Horvath
Mr. Mark Horvath
Division President, Breast and Skeletal Health Solutions
Division President, Breast and Skeletal Health Solutions
22.68K
-0.50%
Mr. Essex D. Mitchell
Mr. Essex D. Mitchell
Chief Operating Officer
Chief Operating Officer
20.34K
+0.41%
Mr. Brandon Schnittker
Mr. Brandon Schnittker
Division President, GYN Surgical Solutions
Division President, GYN Surgical Solutions
17.51K
-0.51%
Mr. Charles J. Dockendorff, CPA
Mr. Charles J. Dockendorff, CPA
Independent Director
Independent Director
13.51K
-49.06%
Dr. Ludwig N. Hantson, Ph.D.
Dr. Ludwig N. Hantson, Ph.D.
Independent Director
Independent Director
10.59K
+30.13%
Detalhamento da receita
Moeda: USDAtualizado em: seg, 6 de abr
Moeda: USDAtualizado em: seg, 6 de abr
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Disposables
644.20M
61.48%
Service
211.00M
20.14%
Capital equipment, components and software
187.20M
17.87%
Other
5.40M
0.52%
Por RegiãoUSD
Nome
Receita
Proporção
United States
773.50M
73.82%
Europe
161.60M
15.42%
Asia
56.70M
5.41%
Rest of World
56.00M
5.34%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Disposables
644.20M
61.48%
Service
211.00M
20.14%
Capital equipment, components and software
187.20M
17.87%
Other
5.40M
0.52%
Distribuição de ações
Atualizado em: dom, 10 de mai
Atualizado em: dom, 10 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Vanguard Capital Management, LLC
6.50%
BlackRock Institutional Trust Company, N.A.
5.76%
State Street Investment Management (US)
4.42%
Vanguard Portfolio Management, LLC
4.31%
Manulife Investment Management (North America) Limited
4.23%
Outro
74.78%
Investidores
Investidores
Proporção
Vanguard Capital Management, LLC
6.50%
BlackRock Institutional Trust Company, N.A.
5.76%
State Street Investment Management (US)
4.42%
Vanguard Portfolio Management, LLC
4.31%
Manulife Investment Management (North America) Limited
4.23%
Outro
74.78%
Tipos de investidores
Investidores
Proporção
Investment Advisor
45.96%
Investment Advisor/Hedge Fund
26.73%
Hedge Fund
15.94%
Research Firm
2.51%
Bank and Trust
2.26%
Sovereign Wealth Fund
2.07%
Pension Fund
1.74%
Individual Investor
0.83%
Family Office
0.05%
Outro
1.91%
Participação acionária institucional
Atualizado em: dom, 5 de abr
Atualizado em: dom, 5 de abr
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2026Q1
1664
217.15M
97.27%
-16.84M
2025Q4
1628
217.20M
97.29%
-20.53M
2025Q3
1587
223.55M
100.44%
-14.31M
2025Q2
1594
230.47M
103.62%
-13.07M
2025Q1
1635
231.71M
103.94%
-14.47M
2024Q4
1617
238.36M
106.18%
-10.05M
2024Q3
1583
240.17M
103.42%
-3.00M
2024Q2
1580
234.77M
100.61%
-6.88M
2024Q1
1595
233.34M
99.37%
-7.61M
2023Q4
1584
235.52M
98.14%
-14.13M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
BlackRock Institutional Trust Company, N.A.
12.86M
5.76%
+424.28K
+3.41%
Dec 31, 2025
State Street Investment Management (US)
9.88M
4.42%
-101.10K
-1.01%
Dec 31, 2025
Manulife Investment Management (North America) Limited
9.44M
4.23%
-1.01M
-9.65%
Dec 31, 2025
HBK Investments, L.P.
8.40M
3.76%
+8.40M
--
Dec 31, 2025
T. Rowe Price Investment Management, Inc.
5.93M
2.66%
-15.62M
-72.47%
Dec 31, 2025
Geode Capital Management, L.L.C.
5.92M
2.65%
+22.02K
+0.37%
Dec 31, 2025
Victory Capital Management Inc.
5.61M
2.51%
+139.87K
+2.56%
Dec 31, 2025
Fidelity Investments Canada ULC
5.17M
2.32%
+5.16M
+32653.16%
Dec 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
First Trust Nasdaq Lux Digi Health Solutions ETF
4.41%
LeaderShares AlphaFactor Tactical Focused ETF
3.17%
John Hancock Fundamental All Cap Core ETF
3.15%
AltShares Event-Driven ETF
2.95%
ProShares Merger ETF
2.78%
First Trust Indxx Medical Devices ETF
2.19%
Strategas Global Policy Opportunities ETF
2.08%
State Street SPDR S&P Health Care Equipment ETF
2.02%
iShares U.S. Medical Devices ETF
1.95%
Brandes US Small-Mid Cap Value ETF
1.94%
Ver Mais
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporção4.41%
LeaderShares AlphaFactor Tactical Focused ETF
Proporção3.17%
John Hancock Fundamental All Cap Core ETF
Proporção3.15%
AltShares Event-Driven ETF
Proporção2.95%
ProShares Merger ETF
Proporção2.78%
First Trust Indxx Medical Devices ETF
Proporção2.19%
Strategas Global Policy Opportunities ETF
Proporção2.08%
State Street SPDR S&P Health Care Equipment ETF
Proporção2.02%
iShares U.S. Medical Devices ETF
Proporção1.95%
Brandes US Small-Mid Cap Value ETF
Proporção1.94%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
